GSK licenses Shigella vaccine candidate to Bharat Biotech for continued development - TheNote.app

GSK press releases

Follow

GSK licenses Shigella vaccine candidate to Bharat Biotech for continued development

GSK plc announced today that it has licensed its Shigella vaccine candidate, altSonflex1-2-3, to Bharat Biotech International Limited.

https://www.gsk.com/en-gb/media/press-releases/gsk-licenses-shigella-vaccine-candidate-to-bharat-biotech-for-continued-development/ gsk.com

RSS Hunter • Jun 12, 2025